View in EDS HTML Full Text PDF Full Text

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.

Saved in:
Bibliographic Details
Title: Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Authors: Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington, USA., Dang L; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Zhang B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Fintzi J; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Chen S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Wang J; Frederick National Laboratory for Cancer Research, Clinical Monitoring Research Program Directorate, Frederick, Maryland, USA., Rouphael NG; Hope Clinic, Department of Medicine, Division of Infectious Diseases, Emory University, Decatur, Georgia, USA., Branche AR; Vaccine and Treatment Evaluation Unit, University of Rochester, Rochester, New York, USA., Diemert DJ; George Washington Vaccine Research Unit, George Washington University, Washington, District of Columbia, USA., Falsey AR; Vaccine and Treatment Evaluation Unit, University of Rochester, Rochester, New York, USA., Losada C; Hope Clinic, Department of Medicine, Division of Infectious Diseases, Emory University, Decatur, Georgia, USA., Baden LR; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Frey SE; Center for Vaccine Development, Saint Louis University, Saint Louis, Missouri, USA., Whitaker JA; Department of Molecular Virology and Microbiology and Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Little SJ; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA., Kamidani S; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University, Atlanta, Georgia, USA., Walter EB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA., Novak RM; Project WISH, University of Illinois at Chicago, Chicago, Illinois, USA., Rupp R; Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA., Jackson LA; Department of Internal Medicine, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Molitor C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Borate B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Babu TM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA., Kottkamp AC; Vaccine and Treatment Evaluation Unit, Manhattan Research Clinic, New York University Grossman School of Medicine, New York, New York, USA., Luetkemeyer AF; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, California, USA., Immergluck LC; Clinical Research Center, Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, Georgia, USA., Presti RM; Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA., Bäcker M; Vaccine and Treatment Evaluation Unit, Long Island Research Clinic, New York University, Long Island School of Medicine, Mineola, New York, USA., Winokur PL; Department of Medicine, University of Iowa College of Medicine, Iowa City, Iowa, USA., Mahgoub SM; Howard University College of Medicine, Howard University Hospital, Washington, District of Columbia, USA., Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Fusco DN; Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA., Atmar RL; Department of Molecular Virology and Microbiology and Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Posavad CM; Infectious Diseases Clinical Research Consortium (IDCRC) Laboratory Operations Unit, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Mu J; Department of Biostatistics, The Emes Company, LLC, Rockville, Maryland, USA., Makowski M; Department of Biostatistics, The Emes Company, LLC, Rockville, Maryland, USA., Makhene MK; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Nayak SU; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Roberts PC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington, USA.
Corporate Authors: Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2025 Feb 05; Vol. 80 (1), pp. 223-227.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39325506
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fong+Y%22">Fong Y</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Dang+L%22">Dang L</searchLink>; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+B%22">Zhang B</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Fintzi+J%22">Fintzi J</searchLink>; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chen+S%22">Chen S</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Frederick National Laboratory for Cancer Research, Clinical Monitoring Research Program Directorate, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Rouphael+NG%22">Rouphael NG</searchLink>; Hope Clinic, Department of Medicine, Division of Infectious Diseases, Emory University, Decatur, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Branche+AR%22">Branche AR</searchLink>; Vaccine and Treatment Evaluation Unit, University of Rochester, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Diemert+DJ%22">Diemert DJ</searchLink>; George Washington Vaccine Research Unit, George Washington University, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Falsey+AR%22">Falsey AR</searchLink>; Vaccine and Treatment Evaluation Unit, University of Rochester, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Losada+C%22">Losada C</searchLink>; Hope Clinic, Department of Medicine, Division of Infectious Diseases, Emory University, Decatur, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Baden+LR%22">Baden LR</searchLink>; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Frey+SE%22">Frey SE</searchLink>; Center for Vaccine Development, Saint Louis University, Saint Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Whitaker+JA%22">Whitaker JA</searchLink>; Department of Molecular Virology and Microbiology and Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Little+SJ%22">Little SJ</searchLink>; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA.<br /><searchLink fieldCode="AU" term="%22Kamidani+S%22">Kamidani S</searchLink>; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Walter+EB%22">Walter EB</searchLink>; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Novak+RM%22">Novak RM</searchLink>; Project WISH, University of Illinois at Chicago, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Rupp+R%22">Rupp R</searchLink>; Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Jackson+LA%22">Jackson LA</searchLink>; Department of Internal Medicine, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Yu+C%22">Yu C</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Magaret+CA%22">Magaret CA</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Molitor+C%22">Molitor C</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Borate+B%22">Borate B</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Babu+TM%22">Babu TM</searchLink>; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Kottkamp+AC%22">Kottkamp AC</searchLink>; Vaccine and Treatment Evaluation Unit, Manhattan Research Clinic, New York University Grossman School of Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Luetkemeyer+AF%22">Luetkemeyer AF</searchLink>; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Immergluck+LC%22">Immergluck LC</searchLink>; Clinical Research Center, Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Presti+RM%22">Presti RM</searchLink>; Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Bäcker+M%22">Bäcker M</searchLink>; Vaccine and Treatment Evaluation Unit, Long Island Research Clinic, New York University, Long Island School of Medicine, Mineola, New York, USA.<br /><searchLink fieldCode="AU" term="%22Winokur+PL%22">Winokur PL</searchLink>; Department of Medicine, University of Iowa College of Medicine, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Mahgoub+SM%22">Mahgoub SM</searchLink>; Howard University College of Medicine, Howard University Hospital, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Goepfert+PA%22">Goepfert PA</searchLink>; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Fusco+DN%22">Fusco DN</searchLink>; Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.<br /><searchLink fieldCode="AU" term="%22Atmar+RL%22">Atmar RL</searchLink>; Department of Molecular Virology and Microbiology and Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Posavad+CM%22">Posavad CM</searchLink>; Infectious Diseases Clinical Research Consortium (IDCRC) Laboratory Operations Unit, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Mu+J%22">Mu J</searchLink>; Department of Biostatistics, The Emes Company, LLC, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Makowski+M%22">Makowski M</searchLink>; Department of Biostatistics, The Emes Company, LLC, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Makhene+MK%22">Makhene MK</searchLink>; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Nayak+SU%22">Nayak SU</searchLink>; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Roberts+PC%22">Roberts PC</searchLink>; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Follmann+D%22">Follmann D</searchLink>; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Gilbert+PB%22">Gilbert PB</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Coronavirus+Variant+Immunologic+Landscape+Trial+%28COVAIL%29+Study+Team%22">Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2025 Feb 05; Vol. 80 (1), pp. 223-227.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39325506
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciae465
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 223
    Titles:
      – TitleFull: Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fong Y
      – PersonEntity:
          Name:
            NameFull: Dang L
      – PersonEntity:
          Name:
            NameFull: Zhang B
      – PersonEntity:
          Name:
            NameFull: Fintzi J
      – PersonEntity:
          Name:
            NameFull: Chen S
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Rouphael NG
      – PersonEntity:
          Name:
            NameFull: Branche AR
      – PersonEntity:
          Name:
            NameFull: Diemert DJ
      – PersonEntity:
          Name:
            NameFull: Falsey AR
      – PersonEntity:
          Name:
            NameFull: Losada C
      – PersonEntity:
          Name:
            NameFull: Baden LR
      – PersonEntity:
          Name:
            NameFull: Frey SE
      – PersonEntity:
          Name:
            NameFull: Whitaker JA
      – PersonEntity:
          Name:
            NameFull: Little SJ
      – PersonEntity:
          Name:
            NameFull: Kamidani S
      – PersonEntity:
          Name:
            NameFull: Walter EB
      – PersonEntity:
          Name:
            NameFull: Novak RM
      – PersonEntity:
          Name:
            NameFull: Rupp R
      – PersonEntity:
          Name:
            NameFull: Jackson LA
      – PersonEntity:
          Name:
            NameFull: Yu C
      – PersonEntity:
          Name:
            NameFull: Magaret CA
      – PersonEntity:
          Name:
            NameFull: Molitor C
      – PersonEntity:
          Name:
            NameFull: Borate B
      – PersonEntity:
          Name:
            NameFull: Babu TM
      – PersonEntity:
          Name:
            NameFull: Kottkamp AC
      – PersonEntity:
          Name:
            NameFull: Luetkemeyer AF
      – PersonEntity:
          Name:
            NameFull: Immergluck LC
      – PersonEntity:
          Name:
            NameFull: Presti RM
      – PersonEntity:
          Name:
            NameFull: Bäcker M
      – PersonEntity:
          Name:
            NameFull: Winokur PL
      – PersonEntity:
          Name:
            NameFull: Mahgoub SM
      – PersonEntity:
          Name:
            NameFull: Goepfert PA
      – PersonEntity:
          Name:
            NameFull: Fusco DN
      – PersonEntity:
          Name:
            NameFull: Atmar RL
      – PersonEntity:
          Name:
            NameFull: Posavad CM
      – PersonEntity:
          Name:
            NameFull: Mu J
      – PersonEntity:
          Name:
            NameFull: Makowski M
      – PersonEntity:
          Name:
            NameFull: Makhene MK
      – PersonEntity:
          Name:
            NameFull: Nayak SU
      – PersonEntity:
          Name:
            NameFull: Roberts PC
      – PersonEntity:
          Name:
            NameFull: Follmann D
      – PersonEntity:
          Name:
            NameFull: Gilbert PB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 02
              Text: 2025 Feb 05
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1